Amlodipine Besylate Tablet
Product Images NDC 82009-027

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 82009-027). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (C45b7a8d 29fb 44b3 929d 8c6e2a41ff11 01)

Chemical structure of amlodipine besylate showing its molecular components and bonds in a two-dimensional diagram with elemental symbols and bonds representing the compound's chemical framework.*

FDA Label Image

Image2 (C45b7a8d 29fb 44b3 929d 8c6e2a41ff11 02)

A Kaplan-Meier curve graph depicts the event rate over time in months for Amlodipine versus placebo groups. The graph includes a hazard ratio of 0.691 with a 95% confidence interval of 0.54 to 0.88 and a p-value of 0.003, indicating statistical data comparing event rates between groups over a 24-month period.*

FDA Label Image

Image3 (C45b7a8d 29fb 44b3 929d 8c6e2a41ff11 03)

A forest plot illustrating hazard ratios with 95% confidence intervals comparing Amlodipine and placebo across patient subgroups, including overall patients, age groups, gender, baseline sitting systolic blood pressure, baseline vessel disease, vessel stenosis, and PCI stent strata. The x-axis represents hazard ratios ranging from 0.0 to 2.0, showing the relative favorability between Amlodipine and placebo treatments.*

FDA Label Image

1 (C45b7a8d 29fb 44b3 929d 8c6e2a41ff11 04)

Packaging label for Amlodipine Besylate Tablets, USP 2.5 mg, containing 90 tablets. Label indicates prescription use (Rx Only) and includes storage instructions and manufacturer information for Cipla Ltd., India, with Quallent Pharmaceuticals Health LLC as labeler. The label features barcode, QR codes, and a designated area for batch overprinting.*

FDA Label Image

2 (C45b7a8d 29fb 44b3 929d 8c6e2a41ff11 05)

Amlodipine Besylate Tablets USP 5 mg oral tablet label for a 1000 tablet package. The label shows the proprietary and generic name, strength of 5 mg, and instructions for storage and dispensing. It is manufactured by Cipla Ltd., India, and labeled for Quallent Pharmaceuticals Health LLC. The label includes a barcode, QR codes, and space for serialization and expiration batch overprinting.*

FDA Label Image

3 (C45b7a8d 29fb 44b3 929d 8c6e2a41ff11 06)

Amlodipine Besylate Tablets, USP 10 mg label, indicating 1000 tablets per package for oral use. The label shows the strength as 10 mg, includes storage instructions to keep at 20°C to 25°C, and notes the product is manufactured by Cipla Ltd., India, for Quallent Pharmaceuticals Health LLC. The label includes a barcode, QR codes, and a designated area for batch overprinting with serial number, expiry, and lot information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.